急性早幼粒细胞白血病合并弥散性血管内凝血:一例病例报告及文献复习
本文报道1例急性早幼粒细胞白血病患者在维甲酸联合亚砷酸诱导化疗期间发生弥散性血管内凝血,经积极血制品输注及凝血因子替代治疗后凝血异常得到纠正,随后经多疗程化疗获得完全缓解,并结合文献复习探讨APL合并DIC与其他疾病所致DIC的差异。
要点
- APL起病凶险、进展迅速,诱导化疗期间易合并DIC,是早期死亡的主要原因。
- 本例患者在维甲酸联合亚砷酸诱导化疗期间发生DIC。
- 经积极血制品输注及凝血因子替代治疗,凝血异常得到纠正,后续多疗程化疗获完全缓解。
核心结论
- 本文报道1例APL患者在维甲酸联合亚砷酸诱导化疗期间发生DIC,经积极血制品输注及凝血因子替代治疗凝血异常得到纠正,随后经多疗程化疗获得完全缓解。
研究设计与样本
- 本文为病例报告并文献复习,报道1例APL合并DIC患者的起病过程及治疗经过。
主要发现
- 该例APL患者在维甲酸联合亚砷酸诱导化疗期间发生DIC。
- 经积极血制品输注及凝血因子替代治疗,凝血异常得到纠正。
- 随后经多疗程化疗获得完全缓解。
关键数值与推荐
- 本文探讨了APL合并DIC与其他类型疾病所致DIC在发病机制、临床表现及治疗策略中的不同之处。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute promyelocytic leukemia (APL) is characterized by an aggressive onset and rapid progression. During induction chemotherapy, it is prone to being complicated by disseminated intravascular coagulation (DIC), which is a leading cause of early death in patients. This study reports a case of APL complicated by DIC during induction therapy with all-trans retinoic acid (ATRA) combined with arsenic trioxide (ATO). The patient's coagulopathy was corrected through active transfusion of blood products and replacement therapy with coagulation factors. Subsequently, complete remission was achieved after multiple courses of chemotherapy. This article provides a detailed description of the patient's disease onset and treatment process, exploring the differences in pathogenesis, clinical presentation, and treatment strategies between APL-associated DIC and DIC caused by other diseases, alongside a review of the relevant literature. 急性早幼粒细胞白血病(APL)起病凶险,进展迅速,诱导化疗期间易合并弥散性血管内凝血(DIC),是患者早期死亡的主要原因。本文报道1例APL患者在维甲酸联合亚砷酸诱导化疗期间发生DIC,经积极血制品输注及凝血因子替代治疗,凝血异常得到纠正,随后经多疗程化疗获得完全缓解。本文对该患者的起病过程及治疗经过进行了详细描述,探讨了APL合并DIC与其他类型疾病所致DIC在发病机制、临床表现及治疗策略中的不同之处,并进行文献复习。.
引用
- Gu WJ, Fu RF, Zhang L, et al. [Acute promyelocytic leukemia with disseminated intravascular coagulation: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 40032346. doi:10.3760/cma.j.cn121090-20241130-00502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。